Fierce Healthcare October 13, 2023
Noah Tong

Approximately 42% of Medicare Advantage plans that offer prescription drug coverage will have a star rating of four or more in 2024, marking yet another substantial decrease from 51% in 2023 and 68% in 2022.

The Centers for Medicare & Medicaid Services released its annual star ratings report for Medicare Advantage and Part D plans Friday, ahead of Medicare’s open enrollment period Oct. 15.

Approximately 74% of MA plan enrollees are currently in contracts that will have four or more stars in 2024, but just 42% of MA plans that offer prescription drug coverage will have an overall rating of four stars or higher.

Star ratings reflect enrollees’ experiences in MA plans and Part D prescription plans, rate on a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Insurance, Medicare Advantage, Provider
Growth in Medicare Advantage Raises Concerns
Study reveals cost differences between Medicare Advantage and traditional Medicare patients in cancer drugs
CMS proposes $21B payment increase for Medicare Advantage in 2026: 10 notes
Medicare Advantage leads to lower cancer drug costs in colorectal cancer
A Stronger Medicare Program—Now And Into The Future

Share This Article